Cervical screening with the smear test stops abruptly at age 65 (Image: Getty Images)
Get the latest news from across Ireland straight to your inbox every single dayInvalid EmailSomething went wrong, please try again later.
Sign up!
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Classical medical teaching is that cervical cancer is a condition affecting primarily “young women”.
That is, women under the age of 50. As a consequence, cervical screening with the smear test stops abruptly at age 65.
London School of Hygiene & Tropical Medicine
Change of strategy could improve health of women living with HIV in the region
Screening women living with HIV in sub-Saharan Africa for cervical precancer using a molecular test is much more accurate than traditional methods and could reduce costly and inconvenient procedures, according to new research published in PLoS Medicine.
The study, led by the London School of Hygiene & Tropical Medicine (LSHTM) in partnership with the University of Ouagadougou in Burkina Faso, Wits Reproductive Health and HIV Institute in South Africa and Montpellier University in France was conducted among over 1,200 women living with HIV in two African countries, Burkina Faso and South Africa.